Akari Therapeutics Plc
Akari Therapeutics Plc (AKTX) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 11 transactions totaling $220.1K, demonstrating a bullish sentiment with $220.1K in net insider flow. The most recent transaction on Nov 1, 2025 involved a transaction of 32,000 shares valued at $24.0K.
AKTX Insider Activity Summary
Who Is Buying AKTX Stock?
No significant insider buying has been recorded for AKTX in the recent period.
Who Is Selling AKTX Stock?
No significant insider selling has been recorded for AKTX in the recent period.
Is Akari Therapeutics Plc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AKTX is bullish with an Insider Alignment Score of 100/100 and a net flow of $220.1K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AKTX Frequently Asked Questions
Understanding AKTX Insider Activity
Insider trading at Akari Therapeutics Plc (AKTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading AKTX stock, having executed 11 transactions in the past 90 days. The most active insider is Mark S. Cohen (Executive), who has made 1 transactions totaling $200.6K.
Related Tools
Track Akari Therapeutics Plc Insider Activity
Get notified when executives and directors at AKTX file new Form 4 transactions